mail2

Spectrum Library

A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.

Publication Date May 2018

Monitoring B-Cell Recovery Is Key in Treating Neurological Diseases With Rituximab

Publication Date May 2018

Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.

Publication Date April 2018

Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation.

Publication Date March 2018

A severe, relapsing case of myelin oligodendrocyte glycoprotein IgG-associated CNS inflammation.

Publication Date February 2018

Rituximab before and during pregnancy A systematic review, and a case series in MS and NMOSD

Publication Date March 2018

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica

Publication Date February 2018

High risk of postpartum relapses in neuromyelitis optica spectrum disorder

Publication Date November 2017

Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease.

Publication Date November 2017

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.

Publication Date November 2017

Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management.

Publication Date December 2017

Bortezomib for Neuromyelitis Optica Spectrum Disorder – A Reply Letter

Tags
Recent Comments

The Power of Rare.

Power of Rare Book Cover

Victoria Jackson’s new book, THE POWER OF RARE: A Blueprint for a Medical Revolution, shares how a revolutionary model was created to speed discoveries that help empower patients and save lives.

LEARN MORE
No Thanks